Mucocutaneous Lymph Node Syndrome
📧 Sign up to get email alerts when something new happens for Mucocutaneous Lymph Node Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-24EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH
Authorised status for Privigen (human normal immunoglobulin IVIg) by CSL Behring GmbH in the EMA; therapeutic areas include various immunolo…
-
EMA approval · 2024-01-11EMA Authorised: Flebogamma DIF (previously Flebogammadif) (human normal immunoglobulin) — Instituto Grifols S.A.
EMA authorises Flebogamma DIF (human normal immunoglobulin) for multiple immunological indications including mucocutaneous lymph node syndro…
-
EMA approval · 2022-06-27EMA Authorised: Kiovig (human normal immunoglobulin (IVIg)) — Takeda Manufacturing Austria AG
Kiovig (human normal immunoglobulin IVIg) has been authorised by EMA for multiple indications including immune thrombocytopenic purpura, bon…